Ann: Results of Annual General Meeting, page-76

Just to clarify...CFDA is 3rd quarter and CFDA is needed to make contracts with China binding.
And management have said they won't use the factory for large volumes until CFDA approval which inturn means CFDA for the factory...so India/Taiwan is a while away.
And CE for teh factory should come through soon. That being said, the Greece deal and any purchases in Aus/NZ will be the only orders to potentially be done in this factory till CFDA.

The US deal isn't binding yet till FDA for the Patch and that's 2H 2018.

Suffice to say, I don't envisage much sp activity for next 3 mths. CE on the factory and Greece deal might see a small uptick but nothing will happen till CFDA.

Management indicated Q1 2018 for this which has essentially now become Q3 2018. Whilst I appreciate timlines can change, its not a good look. Particularly when the raise was done at the worst possible time - when we had momentum.